STADA Arzneimittel AG Logo

STADA Arzneimittel AG

A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.

SAZ | HM

Overview

Corporate Details

ISIN(s):
DE0007251803 (+1 more)
LEI:
529900FMTTLMH0P0DL10
Country:
Germany
Address:
Stadastraße 2 - 18, 61118 Bad Vilbel
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

STADA Arzneimittel AG is a global pharmaceutical company operating with a three-pillar strategy consisting of Generics, Consumer Healthcare, and Specialty Pharmaceuticals. The company is a leading European player in its core segments, ranking as the fourth-largest manufacturer of both generics and consumer healthcare products. Its Generics division focuses on providing affordable medicines. The Consumer Healthcare business is driven by a portfolio of strong regional and 'Local Hero' brands. The Specialty Pharmaceuticals segment develops and markets innovative treatments for specific conditions, including biologic therapies. With a heritage rooted in pharmacies and dating back to 1895, STADA's purpose is to be a trusted partner in caring for people's health.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for STADA Arzneimittel AG and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB
2025-08-20 00:00
Post-Annual General Meeting Information
Datum:20.08.2025
German 9.6 KB

Automate Your Workflow. Get a real-time feed of all STADA Arzneimittel AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for STADA Arzneimittel AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PAION AG Logo
Developed drugs for hospital-based sedation, anesthesia, and critical care.
Germany PA8
Pentixapharm Holding AG Logo
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
Germany PTP
PEPTONIC Medical AB Logo
Develops clinically proven self-care products for women's intimate health.
Sweden PMED
Perseus Proteomics Inc. Logo
Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.
Japan 4882
Pharma Foods International Co., Ltd. Logo
Researches and sells functional ingredients and direct-to-consumer health & beauty products.
Japan 2929
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain PHM
Pharmanutra Logo
Researches and markets nutritional supplements & medical devices for all ages.
Italy PHN
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany PSG
Pharmena S.A. Logo
Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.
Poland PHR
Bulgaria PHRM

Talk to a Data Expert

Have a question? We'll get back to you promptly.